Exploration of Diazaspiro Cores as Piperazine Bioisosteres in the Development of σ2 Receptor Ligands
暂无分享,去创建一个
Ji Youn Lee | R. Mach | G. Look | Chia-Ju Hsieh | N. Izzo | Kuiying Xu | Susan M. Catalano | A. Riad
[1] R. Mach,et al. Screening of σ2 Receptor Ligands and In Vivo Evaluation of 11C-Labeled 6,7-Dimethoxy-2-[4-(4-methoxyphenyl)butan-2-yl]-1,2,3,4-tetrahydroisoquinoline for Potential Use as a σ2 Receptor Brain PET Tracer. , 2022, Journal of medicinal chemistry.
[2] Yurii S. Moroz,et al. Structures of the σ2 receptor enable docking for bioactive ligand discovery , 2021, Nature.
[3] G. Rishton,et al. Sigma‐2 receptor antagonists rescue neuronal dysfunction induced by Parkinson’s patient brain‐derived α‐synuclein , 2020, Journal of neuroscience research.
[4] F. Berardi,et al. PB28, the Sigma-1 and Sigma-2 Receptors Modulator With Potent Anti–SARS-CoV-2 Activity: A Review About Its Pharmacological Properties and Structure Affinity Relationships , 2020, Frontiers in Pharmacology.
[5] J. Trojanowski,et al. The Sigma-2 Receptor/TMEM97, PGRMC1, and LDL Receptor Complex Are Responsible for the Cellular Uptake of Aβ42 and Its Protein Aggregates , 2020, Molecular Neurobiology.
[6] P. Cottone,et al. Role of Sigma Receptors in Alcohol Addiction , 2019, Front. Pharmacol..
[7] J. Karanicolas,et al. Leveraging a Low-Affinity Diazaspiro Orthosteric Fragment to Reduce Dopamine D3 Receptor (D3R) Ligand Promiscuity across Highly Conserved Aminergic G-Protein-Coupled Receptors (GPCRs). , 2019, Journal of medicinal chemistry.
[8] N. Fazio,et al. Benzimidazolone-based selective σ2 receptor ligands: Synthesis and pharmacological evaluation. , 2019, European journal of medicinal chemistry.
[9] R. Mach,et al. Sigma-2 Receptor/TMEM97 and PGRMC-1 Increase the Rate of Internalization of LDL by LDL Receptor through the Formation of a Ternary Complex , 2018, Scientific Reports.
[10] R. Mach,et al. Examination of Diazaspiro Cores as Piperazine Bioisosteres in the Olaparib Framework Shows Reduced DNA Damage and Cytotoxicity. , 2018, Journal of medicinal chemistry.
[11] R. Franco,et al. Cocaine Effects on Dopaminergic Transmission Depend on a Balance between Sigma-1 and Sigma-2 Receptor Expression , 2018, Front. Mol. Neurosci..
[12] R. Mach,et al. Highly Selective Dopamine D3 Receptor Antagonists with Arylated Diazaspiro Alkane Cores. , 2017, Journal of medicinal chemistry.
[13] P. Ray,et al. Sigma 2 Receptor/Tmem97 Agonists Produce Long Lasting Antineuropathic Pain Effects in Mice. , 2017, ACS chemical neuroscience.
[14] Charles L. Brooks,et al. CHARMM‐GUI ligand reader and modeler for CHARMM force field generation of small molecules , 2017, J. Comput. Chem..
[15] Michael D. Wood,et al. Identification of the gene that codes for the σ2 receptor , 2017, Proceedings of the National Academy of Sciences.
[16] R. Mach,et al. Pd-catalyzed arylation of linear and angular spirodiamine salts under aerobic conditions. , 2017, Tetrahedron letters.
[17] R. Mach,et al. Pd-Catalyzed Synthesis of Piperazine Scaffolds Under Aerobic and Solvent-Free Conditions. , 2016, Organic letters.
[18] H. Schmidt,et al. Crystal structure of the human σ1 receptor , 2016, Nature.
[19] T. Hiranita. Identification of the Sigma-2 Receptor: Distinct from the Progesterone Receptor Membrane Component 1 (PGRMC1) , 2016, Journal of alcoholism and drug dependence.
[20] Alexander D. MacKerell,et al. CHARMM-GUI Input Generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM/OpenMM Simulations Using the CHARMM36 Additive Force Field , 2015, Journal of chemical theory and computation.
[21] C. McCurdy,et al. The Sigma-2 Receptor and Progesterone Receptor Membrane Component 1 are Different Binding Sites Derived From Independent Genes , 2015, EBioMedicine.
[22] F. Berardi,et al. Elements in support of the 'non-identity' of the PGRMC1 protein with the σ2 receptor. , 2015, European journal of pharmacology.
[23] Gary Look,et al. Alzheimer's Therapeutics Targeting Amyloid Beta 1–42 Oligomers II: Sigma-2/PGRMC1 Receptors Mediate Abeta 42 Oligomer Binding and Synaptotoxicity , 2014, PloS one.
[24] Alexander D. MacKerell,et al. CHARMM all-atom additive force field for sphingomyelin: elucidation of hydrogen bonding and of positive curvature. , 2014, Biophysical journal.
[25] R. Mach,et al. The σ2 receptor: a novel protein for the imaging and treatment of cancer. , 2013, Journal of medicinal chemistry.
[26] Ramu Anandakrishnan,et al. H++ 3.0: automating pK prediction and the preparation of biomolecular structures for atomistic molecular modeling and simulations , 2012, Nucleic Acids Res..
[27] Hyeon Joo,et al. OPM database and PPM web server: resources for positioning of proteins in membranes , 2011, Nucleic Acids Res..
[28] Chris Morley,et al. Open Babel: An open chemical toolbox , 2011, J. Cheminformatics.
[29] J. Poupaert,et al. Synthesis and pharmacological evaluation of indole-based sigma receptor ligands. , 2011, European journal of medicinal chemistry.
[30] R. Hotchkiss,et al. Identification of the PGRMC1 protein complex as the putative sigma-2 receptor binding site , 2011, Nature communications.
[31] J Andrew McCammon,et al. BINANA: a novel algorithm for ligand-binding characterization. , 2011, Journal of molecular graphics & modelling.
[32] E. Lacivita,et al. Analogues of σ receptor ligand 1-cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine (PB28) with added polar functionality and reduced lipophilicity for potential use as positron emission tomography radiotracers. , 2011, Journal of medicinal chemistry.
[33] S. Buch,et al. The sigma-1 receptor chaperone as an inter-organelle signaling modulator. , 2010, Trends in pharmacological sciences.
[34] Alexander D. MacKerell,et al. Update of the CHARMM all-atom additive force field for lipids: validation on six lipid types. , 2010, The journal of physical chemistry. B.
[35] David S. Goodsell,et al. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility , 2009, J. Comput. Chem..
[36] F. Berardi,et al. 1-Cyclohexylpiperazine and 3,3-Dimethylpiperidine Derivatives as Sigma-1 (σ1) and Sigma-2 (σ2) Receptor Ligands: A Review , 2009 .
[37] Taehoon Kim,et al. CHARMM‐GUI: A web‐based graphical user interface for CHARMM , 2008, J. Comput. Chem..
[38] R. Mach,et al. Synthesis of N-substituted 9-azabicyclo[3.3.1]nonan-3α-yl carbamate analogs as σ2 receptor ligands , 2006 .
[39] Gregory A. Grothaus,et al. A simple clustering algorithm can be accurate enough for use in calculations of pKs in macromolecules , 2006, Proteins.
[40] Lenwood S. Heath,et al. H++: a server for estimating pKas and adding missing hydrogens to macromolecules , 2005, Nucleic Acids Res..
[41] R. Mach,et al. Conformationally-flexible benzamide analogues as dopamine D3 and σ2 receptor ligands , 2004 .
[42] E. Kempner,et al. Purification, molecular cloning, and expression of the mammalian sigma1-binding site. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[43] E. Meier,et al. Sigma ligands with subnanomolar affinity and preference for the sigma 2 binding site. 1. 3-(omega-aminoalkyl)-1H-indoles. , 1995, Journal of medicinal chemistry.
[44] E. Meier,et al. Sigma ligands with subnanomolar affinity and preference for the sigma 2 binding site. 2. Spiro-joined benzofuran, isobenzofuran, and benzopyran piperidines. , 1995, Journal of medicinal chemistry.
[45] W. Bowen,et al. Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines. , 1995, Cancer research.
[46] W. Bowen,et al. Rat liver and kidney contain high densities of σ1 and σ2 receptors: characterization by ligand binding and photoaffinity labeling , 1994 .